Royal London Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Sell |
46,571
-3,061
| -6% | -$1.61M | 0.06% | 273 |
|
|
2025
Q1 | $31.5M | Buy |
49,632
+5,548
| +13% | +$3.52M | 0.07% | 234 |
|
|
2024
Q4 | $31.4M | Buy |
44,084
+409
| +0.9% | +$291K | 0.08% | 216 |
|
|
2024
Q3 | $45.9M | Buy |
43,675
+1,152
| +3% | +$1.21M | 0.11% | 159 |
|
|
2024
Q2 | $44.7M | Buy |
42,523
+1,463
| +4% | +$1.54M | 0.11% | 151 |
|
|
2024
Q1 | $39.5M | Sell |
41,060
-589
| -1% | -$567K | 0.1% | 172 |
|
|
2023
Q4 | $36.6M | Buy |
41,649
+1,068
| +3% | +$938K | 0.1% | 168 |
|
|
2023
Q3 | $33.4M | Buy |
40,581
+1,652
| +4% | +$1.36M | 0.11% | 164 |
|
|
2023
Q2 | $28M | Buy |
38,929
+2,231
| +6% | +$1.6M | 0.09% | 183 |
|
|
2023
Q1 | $30.2M | Sell |
36,698
-149
| -0.4% | -$122K | 0.12% | 142 |
|
|
2022
Q4 | $26.6M | Buy |
36,847
+1,824
| +5% | +$1.32M | 0.12% | 156 |
|
|
2022
Q3 | $24.1M | Sell |
35,023
-1,305
| -4% | -$900K | 0.12% | 150 |
|
|
2022
Q2 | $21.5M | Buy |
36,328
+316
| +0.9% | +$187K | 0.1% | 173 |
|
|
2022
Q1 | $25.2M | Buy |
36,012
+1,830
| +5% | +$1.28M | 0.1% | 175 |
|
|
2021
Q4 | $21.6M | Sell |
34,182
-602
| -2% | -$380K | 0.08% | 202 |
|
|
2021
Q3 | $21M | Buy |
34,784
+512
| +1% | +$310K | 0.09% | 196 |
|
|
2021
Q2 | $19.1M | Sell |
34,272
-1,858
| -5% | -$1.04M | 0.08% | 212 |
|
|
2021
Q1 | $17.1M | Buy |
36,130
+990
| +3% | +$469K | 0.08% | 215 |
|
|
2020
Q4 | $17M | Sell |
35,140
-2,271
| -6% | -$1.1M | 0.09% | 199 |
|
|
2020
Q3 | $21.5M | Sell |
37,411
-32
| -0.1% | -$18.4K | 0.13% | 144 |
|
|
2020
Q2 | $22.9M | Buy |
37,443
+5,722
| +18% | +$3.49M | 0.16% | 127 |
|
|
2020
Q1 | $15M | Sell |
31,721
-143
| -0.4% | -$67.7K | 0.12% | 176 |
|
|
2019
Q4 | $11.9M | Sell |
31,864
-231
| -0.7% | -$86.4K | 0.08% | 233 |
|
|
2019
Q3 | $8.9M | Buy |
32,095
+210
| +0.7% | +$58.3K | 0.07% | 284 |
|
|
2019
Q2 | $9.98M | Sell |
31,885
-389
| -1% | -$122K | 0.09% | 218 |
|
|
2019
Q1 | $13.3M | Sell |
32,274
-1,724
| -5% | -$708K | 0.1% | 207 |
|
|
2018
Q4 | $12.3M | Buy |
33,998
+1,857
| +6% | +$673K | 0.11% | 202 |
|
|
2018
Q3 | $13M | Sell |
32,141
-1,499
| -4% | -$606K | 0.13% | 161 |
|
|
2018
Q2 | $11.6M | Buy |
+33,640
| New | +$11.6M | 0.12% | 188 |
|
|
2016
Q2 | $9.61M | Sell |
27,509
-7,067,884
| -100% | -$2.47B | 0.16% | 139 |
|
|
2016
Q1 | $20K | Buy |
7,095,393
+7,066,511
| +24,467% | +$19.9K | 0.03% | 467 |
|
|
2015
Q4 | $15.8M | Buy |
28,882
+402
| +1% | +$220K | 0.24% | 97 |
|
|
2015
Q3 | $13.2M | Buy |
+28,480
| New | +$13.2M | 0.21% | 111 |
|
|
2014
Q4 | $101K | Buy |
24,653
+5,701
| +30% | +$23.3K | 0.19% | 125 |
|
|
2014
Q3 | $6.73M | Buy |
18,952
+1,000
| +6% | +$355K | 0.17% | 136 |
|
|
2014
Q2 | $6.12M | Sell |
17,952
-79
| -0.4% | -$26.9K | 0.14% | 165 |
|
|
2014
Q1 | $5.25M | Sell |
18,031
-216
| -1% | -$62.9K | 0.12% | 188 |
|
|
2013
Q4 | $5.01M | Buy |
18,247
+876
| +5% | +$240K | 0.13% | 184 |
|
|
2013
Q3 | $5.29M | Buy |
17,371
+395
| +2% | +$120K | 0.14% | 170 |
|
|
2013
Q2 | $3.98M | Buy |
+16,976
| New | +$3.98M | 0.12% | 199 |
|